AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glinvika Tablet ER

Prescription Icon
Prescription Required

Marketer

Agresco Pharma

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glinvika Tablet ER

Diabex Duo ER tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabex Duo ER should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medication as prescribed, even if feeling well or experiencing controlled blood sugar; discontinuation without medical consultation can lead to elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Diabex Duo ER is a component of a comprehensive treatment plan encompassing a healthy diet, regular exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Carry a fast-acting glucose source (e.g., sugary foods or juice) to counteract hypoglycemia. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is possible. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Inform your physician of any history of heart conditions before commencing treatment; pregnancy or breastfeeding requires medical consultation. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glinvika Tablet ER

Diabetes mellitus type 2

Major Benefits of Glinvika Tablet ER:

Consume this medication according to your physician's prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glinvika Tablet ER with a meal.

Common Side effects of Glinvika Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glinvika Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glinvika ER tablet whole; avoid chewing, crushing, or breaking it. It should be administered with food.

How Glinvika Tablet ER works:

Glinvika ER tablets contain a dual-action formulation of gliclazide and metformin, both used in diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glinvika ER tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glinvika tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glinvika tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glinvika Tablet ER cautiously, potentially requiring dosage modification. Consult your physician for guidance. Glinvika Tablet ER is contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glinvika ER tablets to individuals with hepatic impairment. Dosage modifications for Glinvika ER may be necessary. Physician consultation is advised. A low initial dose of Glinvika ER is typically recommended for patients exhibiting mild to moderate liver dysfunction; its use is contraindicated in cases of severe liver disease.

What if you forget to take Glinvika Tablet ER :

Should you forget a Glinvika Extended-Release tablet, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glinvika Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Treatment

FAQs on Glinvika Tablet ER

Glinvika ER tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glinvika ER is not suitable for type 1 diabetes.
Glinvika Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glinvika Tablet ER can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Glinvika Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glinvika Tablet ER and seek immediate medical attention.
Prolonged Glinvika Tablet ER use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some research.
Glinvika Tablet ER is contraindicated in patients allergic to any of its components or excipients, and in those with moderate-to-severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glinvika ER tablets and alcohol is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Glinvika ER tablets combine gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glinvika ER is not suitable for type 1 DM.
Glinvika Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glinvika ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glinvika Tablet ER can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is best avoided in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glinvika Tablet ER and seek immediate medical attention.
Prolonged Glinvika Tablet ER use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some research.
Glinvika Tablet ER is contraindicated in patients allergic to any of its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Glinvika ER tablets and alcohol is unsafe. Alcohol can worsen hypoglycemia and raise the risk of lactic acidosis.
Glinvika Tablet ER
156
MRP 181
13% off